PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012 2013 2014
The NRL is now a division in the Institute of HIV/AIDS & other Diseases Prevention & Control (IHDPC) under the corporate structure of the Rwanda Biomedical Centre (RBC) of the MOH. The NRL continues to strengthen the laboratory networks capacity to deliver quality laboratory services for HIV/AIDS prevention, diagnosis, & care & treatment programs. The NRLs objectives include strengthening human resource capacity at NRL & within the national laboratory network (LN), strengthening administrative & management systems, strengthening the LNs provision of logistical & technical support for the provision of the minimum package of laboratory services at each tier of the LN pyramidal structure linked from NRL to referral hospitals, & district hospitals to primary health care site laboratories. Support & TA will be provided to the LN in laboratory infrastructure & services (labs in 4 referral hospitals, 45 district hospitals & over 450 private & public health centers). The MOH & RBC/NRL will continue to work with the Global Fund, Presidents Malaria Initiative (PMI), World Bank (WB), World Health Organization (WHO) & other stakeholders to further develop & sustain the program.
The NRL will contribute to PEPFARs 3 major goals by ensuring quality HIV serology nationwide; strengthening capacity for the diagnosis of opportunistic infections as well as a national network of CD4 testing laboratories; widespread hematology & biochemistry capacity for monitoring patients on ART; & the scale up of patient viral load monitoring laboratories as well as ARV drug resistance. The LN will benefit from a stronger sample transportation system & also improve the turnaround time for service delivery within the LN.
No vehicles have been purchased or leased or planned under this mechanism.
In COP12, the NRL will focus on the continuous strengthening of the laboratory network (LN) to provide laboratory services in the screening of HIV (to include rapid HIV testing and early infant diagnosis of HIV using PCR), monitoring the clinical prognosis of patients on antiretroviral (ARVs), the laboratory diagnosis of parasitic and microbial opportunistic infections (OIs) and quality improvement and management programs to include but not limited to laboratory accreditation process for 5 laboratories using the WHO AFRO Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA), external quality assessments, supervision-mentorship and in-service training. The goals include continuous reinforcement of capacities of personnel within the LN, providing NRL and the LN with equipment and reagents, strengthening the QA/QC program in the LN, and ensuring proper transfer of samples and data with the utilization of the Laboratory Information System (LIS). Care and ARV treatment activities are directly supported by ensuring quality HIV serology nationwide, strengthening capacity for the diagnosis of opportunistic infections, as well as a national network of CD4 testing laboratories, widespread hematology and biochemistry capacity for monitoring patients on ART and the scale up of patient viral load monitoring laboratories as well as ARV drug resistance at the NRL. Prevention of infection of critical health workers will be achieved through training in biosafety precautions and good laboratory practices. Furthermore, by implementing the accreditation process within the LN, laboratory services will be improved to satisfy the clienteles desired quality and working environment. Also, the LN will benefit from a stronger sample transportation system and also improve the turnaround time for service delivery within the LN.None
